Increased expression of annexin I is associated with drug‐resistance in nasopharyngeal carcinoma and other solid tumors
- 24 June 2009
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 3 (6) , 654-662
Abstract
Adjuvant chemotherapy alongside radiotherapy is one of the effective therapies in nasopharyngeal carcinoma (NPC) treatment. However, the appearance of drug resistance is a major obstacle for anti‐cancer chemotherapy and often causes failure of the chemotherapy. In this study, a drug‐resistant gene annexin I (ANX‐I) was identified by comparing differentially expressed proteins between a cisplatin (CDDP)‐resistant NPC cell line CNE2‐CDDP and parental CNE2 cells using 2‐DE. When ANX‐I was transfected into CNE2 cells, the CDDP resistance of CNE2 cells was dramatically increased. The drug‐resistant ability of ANX‐I was demonstrated by both in vitro and in vivo assays. The association of ANX‐I expression with clinical features was also investigated. Increased expression of ANX‐I was significantly associated with disease relapse in NPC (ppp<0.001), respectively. Taken together, our findings suggest that ANX‐I plays an important role in drug resistance.Keywords
Funding Information
- Research Grant Council Grant (HKU 7393/04 M)
- Major State Basic Research Program of China (2006CB910104)
- Sun Yat-Sen University “Hundred Talents Program” (85000-3171311)
- Foundation of Guangzhou Science and Technology Bureau (2005Z1-E0131)
This publication has 20 references indexed in Scilit:
- Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug TreatmentCurrent Medicinal Chemistry, 2006
- Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Reirradiation for Locally Recurrent Nasopharyngeal CarcinomaAmerican Journal of Clinical Oncology, 2005
- Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two Phase III TrialsJournal of Clinical Oncology, 2005
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Concurrent and Adjuvant Chemotherapy for Nasopharyngeal Carcinoma: A Factorial StudyJournal of Clinical Oncology, 2004
- P-glycoprotein: from genomics to mechanismOncogene, 2003
- Treatment outcome after radiotherapy alone for patients with Stage I–II nasopharyngeal carcinomaCancer, 2003
- Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4Nature Genetics, 2002
- Nasopharyngeal Carcinoma, with Emphasis on its Relationship to Epstein-Barr VirusAnnals of Otology, Rhinology & Laryngology, 1997